Pregabalin monotherapy for epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pregabalin Monotherapy for Epilepsy." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433114/all/Pregabalin_monotherapy_for_epilepsy:_Cochrane_systematic_review.
Pregabalin monotherapy for epilepsy. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433114/all/Pregabalin_monotherapy_for_epilepsy:_Cochrane_systematic_review. Accessed January 8, 2026.
Pregabalin monotherapy for epilepsy. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433114/all/Pregabalin_monotherapy_for_epilepsy:_Cochrane_systematic_review
Pregabalin Monotherapy for Epilepsy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433114/all/Pregabalin_monotherapy_for_epilepsy:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pregabalin monotherapy for epilepsy
ID - 433114
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433114/all/Pregabalin_monotherapy_for_epilepsy:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

